Latinovic-Golic Sonja, Walch Michael, Sundstrom Hanna, Dumrese Claudia, Groscurth Peter, Ziegler Urs
Division of Cell Biology, Institute of Anatomy, Zürich, Switzerland.
BMC Immunol. 2007 Jun 27;8:9. doi: 10.1186/1471-2172-8-9.
Granulysin, a cytotoxic protein expressed in human natural killer cells and activated T lymphocytes, exhibits cytolytic activity against a variety of intracellular microbes. Expression and transcription have been partially characterised in vitro and four transcripts (NKG5, 519, 520, and 522) were identified. However, only a single protein product of 15 kDa was found, which is subsequently processed to an active 9 kDa protein.
In this study we investigated generation of granulysin in lymphokine activated killer (LAK) cells and antigen (Listeria) specific T-cells. Semiquantitative RT-PCR revealed NKG5 to be the most prominent transcript. It was found to be up-regulated in a time-dependent manner in LAK cells and antigen specific T-cells and their subsets. Two isoforms of 519 mRNA were up-regulated under IL-2 and antigen stimulation. Moreover, two novel transcripts, without any known function, comprising solely parts of the 5 prime region of the primary transcript, were detected. A significant increase of granulysin expressing LAK cells as well as antigen specific T-cells was shown by fluorescence microscopy. On the subset level, increase in CD4+ granulysin expressing cells was found only under antigen stimulation. Immunoblotting showed the 15 kDa form of granulysin to be present in the first week of stimulation either with IL-2 or with bacterial antigen. Substantial processing to the 9 kDa form was detected during the first week in LAK cells and in the second week in antigen specific T-cells.
This first comprehensive study of granulysin gene regulation in primary cultured human lymphocytes shows that the regulation of granulysin synthesis in response to IL-2 or bacterial antigen stimulation occurs at several levels: RNA expression, extensive alternative splicing and posttranslational processing.
颗粒溶素是一种在人类自然杀伤细胞和活化T淋巴细胞中表达的细胞毒性蛋白,对多种细胞内微生物具有溶细胞活性。其表达和转录在体外已得到部分表征,并鉴定出四种转录本(NKG5、519、520和522)。然而,仅发现一种15 kDa的单一蛋白产物,随后该产物被加工成活性9 kDa蛋白。
在本研究中,我们调查了颗粒溶素在淋巴因子激活的杀伤(LAK)细胞和抗原(李斯特菌)特异性T细胞中的生成情况。半定量逆转录聚合酶链反应(RT-PCR)显示NKG5是最主要的转录本。发现在LAK细胞、抗原特异性T细胞及其亚群中,NKG5以时间依赖性方式上调。519 mRNA的两种异构体在白细胞介素-2(IL-2)和抗原刺激下上调。此外,还检测到两种无任何已知功能的新转录本,它们仅包含初级转录本5'区域的部分片段。荧光显微镜检查显示,表达颗粒溶素的LAK细胞以及抗原特异性T细胞显著增加。在亚群水平上,仅在抗原刺激下发现表达颗粒溶素的CD4+细胞增加。免疫印迹显示,在刺激的第一周,无论是用IL-2还是细菌抗原刺激,均存在15 kDa形式的颗粒溶素。在LAK细胞的第一周以及抗原特异性T细胞的第二周检测到大量加工成9 kDa形式的颗粒溶素。
这项对原代培养的人淋巴细胞中颗粒溶素基因调控的首次全面研究表明,颗粒溶素合成对IL-2或细菌抗原刺激的调控发生在多个水平:RNA表达、广泛的可变剪接和翻译后加工。